| Cannabinoid physiology and pharmacology: 30 years of progress AC Howlett, CS Breivogel, SR Childers, SA Deadwyler, RE Hampson, ... Neuropharmacology 47, 345-358, 2004 | 839 | 2004 |
| Evidence for a new G protein-coupled cannabinoid receptor in mouse brain CS Breivogel, G Griffin, V Di Marzo, BR Martin Molecular pharmacology 60 (1), 155-163, 2001 | 695 | 2001 |
| Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice: Evidence for Non‐CB1, Non‐CB2 Receptor … V Di Marzo, CS Breivogel, Q Tao, DT Bridgen, RK Razdan, AM Zimmer, ... Journal of neurochemistry 75 (6), 2434-2444, 2000 | 522 | 2000 |
| Chronic ▵9‐Tetrahydrocannabinol Treatment Produces a Time‐Dependent Loss of Cannabinoid Receptors and Cannabinoid Receptor‐Activated G Proteins in … CS Breivogel, SR Childers, SA Deadwyler, RE Hampson, LJ Vogt, ... Journal of neurochemistry 73 (6), 2447-2459, 1999 | 324 | 1999 |
| The functional neuroanatomy of brain cannabinoid receptors CS Breivogel, SR Childers Neurobiology of disease 5 (6), 417-431, 1998 | 273 | 1998 |
| Regional differences in cannabinoid receptor/G-protein coupling in rat brain CS Breivogel, LJ Sim, SR Childers Journal of Pharmacology and Experimental Therapeutics 282 (3), 1632-1642, 1997 | 250 | 1997 |
| Cannabinoid receptor agonist efficacy for stimulating [35S] GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity CS Breivogel, DE Selley, SR Childers Journal of Biological Chemistry 273 (27), 16865-16873, 1998 | 212 | 1998 |
| Cannabis and endogenous cannabinoid systems SR Childers, CS Breivogel Drug and alcohol dependence 51 (1-2), 173-187, 1998 | 212 | 1998 |
| Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein α-subunits with different potencies PL Prather, NA Martin, CS Breivogel, SR Childers Molecular pharmacology 57 (5), 1000-1010, 2000 | 149 | 2000 |
| Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition CS Breivogel, SR Childers Journal of Pharmacology and Experimental Therapeutics 295 (1), 328-336, 2000 | 122 | 2000 |
| Basic neuroanatomy and neuropharmacology of cannabinoids CS Breivogel, LJ Sim-Selley International Review of Psychiatry 21 (2), 113-121, 2009 | 100 | 2009 |
| Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment DE Selley, EJ Nestler, CS Breivogel, SR Childers Brain research 746 (1-2), 10-18, 1997 | 96 | 1997 |
| Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. DE Selley, CS Breivogel, SR Childers Molecular pharmacology 44 (4), 731-741, 1993 | 96 | 1993 |
| Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide V Di Marzo, C Breivogel, T Bisogno, D Melck, G Patrick, Q Tao, A Szallasi, ... European journal of pharmacology 406 (3), 363-374, 2000 | 89 | 2000 |
| Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− mice CS Breivogel, JM Lambert, S Gerfin, JW Huffman, RK Razdan Behavioural pharmacology 19 (4), 298-307, 2008 | 85 | 2008 |
| The effects of Δ9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors CS Breivogel, SM Scates, IO Beletskaya, OB Lowery, MD Aceto, ... European journal of pharmacology 459 (2-3), 139-150, 2003 | 84 | 2003 |
| Acute and chronic effects of opioids on δ and μ receptor activation of G proteins in NG108‐15 and SK‐N‐SH cell membranes CS Breivogel, DE Selley, SR Childers Journal of neurochemistry 68 (4), 1462-1472, 1997 | 77 | 1997 |
| Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors in rats CE Farquhar, CS Breivogel, TF Gamage, EA Gay, BF Thomas, RM Craft, ... Drug and alcohol dependence 194, 20-27, 2019 | 61 | 2019 |
| Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids CS Breivogel, JM Walker, SM Huang, MB Roy, SR Childers Neuropharmacology 47 (1), 81-91, 2004 | 59 | 2004 |
| Antiemetic and motor-depressive actions of CP55, 940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation NA Darmani, LJ Sim-Selley, BR Martin, JJ Janoyan, JL Crim, B Parekh, ... European journal of pharmacology 459 (1), 83-95, 2003 | 52 | 2003 |
Vincenzo Di MarzoConsiglio nazionale delle RicercheVerified email at icb.cnr.it
